FDA approves remote reprogramming feature for cochlear implant

The FDA has approved hearing implant maker Cochlear Limited ’s submission for a new remote feature that would allow specialists to perform follow-up programming on a patient’s cochlear implant remotely, a la a telemedicine platform.
Source: mobihealthnews - Category: Information Technology Source Type: news